Highly multiplex guide RNA expression units of CRISPR/Cas9 were completely stable using cosmid amplification in a novel polygonal structure. (29th October 2019)

• Record Type: Journal Article
• Authors: Nakanishi, Tomoko; Maekawa, Aya; Tabata, Hirotaka; Yoshioka, Takashi; Pei, Zheng; Sato, Kumiko; Mori, Mai; Kato, Masaya; Saito, Izumu
• Is Part Of: Journal of gene medicine. Volume 21:Number 11(2019)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2019-10-29
• Subjects: cosmid -- double nicking -- lambda packaging -- multiplex guide RNA -- non‐viral vector -- nucleic acid therapy; Genetic transformation -- Periodicals; Gene Transfer -- Periodicals; Gene Therapy -- Periodicals; 616.042
• DOI: 10.1002/jgm.3115
• Languages: English
• ISSNs: 1099-498X

Abstract

Abstract: Background: Genome editing using the CRISPR/Cas9 system is now well documented in basic studies and is expected to be applied to gene therapy. Simultaneous expression of multiplex guide RNA (gRNA) and Cas9/Cas9 derivative is attractive for the efficient knockout of genes and a safe double‐nicking strategy. However, such use is limited because highly multiplex gRNA‐expressing units are difficult to maintain stably in plasmids as a result of deletion via homologous recombination. Methods: Lambda in vitro packaging was used instead of transformation for the construction and preparation of large, cos‐containing plasmid (cosmid). Polymerase chain reaction fragments containing multiplex gRNA units were obtained using the Four‐guide Tandem method. Transfection was performed by lipofection. Results: We constructed novel cosmids consisting of linearized plasmid‐DNA fragments containing up to 16 copies of multiplex gRNA‐expressing units as trimer or tetramer (polygonal cosmids). These cosmids behaved as if they were monomer plasmids, and multiplex units could stably be maintained and amplified with a lack of deletion. Surprisingly, the deleted cosmid was removed out simply by amplifying the cosmid stock using lambda packaging. The DNA fragments containing multiplex gRNA‐units and Cas9 were transfected to 293 cells and were found to disrupt the X gene of hepatitis B virus by deleting a large region between the predicted sites. Conclusions: We present a simple method for overcoming the problem of constructing plasmids stably containing multiplex gRNA‐expressing units. The method may enable the production of very large amounts of DNA fragments expressing intact, highly‐multiplex gRNAs and Cas9/Cas9 derivatives for safe and efficient genome‐editing therapy using non‐viral vectors.